Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Nov 30, 2025 | (FY)May 31, 2025 | (Q6)Nov 30, 2024 | (FY)May 31, 2024 | (Q6)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q9)Feb 28, 2023 | (Q6)Nov 30, 2022 | (Q1)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 22.01%18.91M | 2.85%31.56M | 1.22%15.49M | 1.25%30.68M | -6.49%15.31M | -20.79%7.23M | 42.35%30.3M | 61.92%23.16M | 81.39%16.37M | 247.22%9.13M |
| Operating income | 22.01%18.91M | 2.85%31.56M | 1.22%15.49M | 1.25%30.68M | -6.49%15.31M | -20.79%7.23M | 42.35%30.3M | 61.92%23.16M | 81.39%16.37M | 247.22%9.13M |
| Cost of sales | -20.35%-13.46M | -0.21%-22.17M | -0.58%-11.18M | 5.37%-22.12M | 12.45%-11.12M | 23.93%-5.35M | -31.94%-23.38M | -47.10%-18.05M | -63.53%-12.7M | -160.57%-7.04M |
| Operating expenses | -20.35%-13.46M | -0.21%-22.17M | -0.58%-11.18M | 5.37%-22.12M | 12.45%-11.12M | 23.93%-5.35M | -31.94%-23.38M | -47.10%-18.05M | -63.53%-12.7M | -160.57%-7.04M |
| Gross profit | 26.33%5.45M | 9.67%9.39M | 2.91%4.31M | 23.63%8.56M | 14.14%4.19M | -10.21%1.87M | 94.03%6.92M | 151.50%5.11M | 191.50%3.67M | 2,958.90%2.09M |
| Selling expenses | -34.93%-1.21M | -36.95%-1.86M | -43.38%-899K | -10.15%-1.36M | -14.42%-627K | -4.76%-286K | -25.87%-1.23M | -20.54%-892K | -24.83%-548K | -31.88%-273K |
| Administrative expenses | -7.71%-2.71M | 6.69%-5.54M | 8.28%-2.52M | -37.79%-5.94M | 6.80%-2.74M | 30.76%-1.18M | -32.15%-4.31M | -56.11%-4.09M | -58.57%-2.94M | -72.60%-1.71M |
| Impairment and provision | ---- | -26.62%-666K | ---- | 65.62%-526K | ---- | ---- | -19.16%-1.53M | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -26.62%-666K | ---- | 65.62%-526K | ---- | ---- | -19.16%-1.53M | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---27K | ---- |
| Special items of operating profit | -6.92%471K | 7.58%1.04M | -16.91%506K | -0.82%963K | 17.12%609K | -34.92%233K | 129.01%971K | 153.95%739K | 168.04%520K | 347.50%358K |
| Operating profit | 42.23%1.99M | 38.56%2.36M | -1.82%1.4M | 106.55%1.7M | 112.50%1.43M | 37.42%639K | 151.27%825K | 183.33%865K | 179.81%672K | 139.11%465K |
| Financing cost | -126.09%-104K | -7.52%-143K | 33.33%-46K | -37.11%-133K | ---69K | -133.33%-35K | ---97K | -8.93%-61K | ---- | 25.00%-15K |
| Share of profits of associates | -16,033.33%-484K | -957.38%-523K | -104.35%-3K | -32.22%61K | --69K | --47K | --90K | ---1K | ---- | ---- |
| Earning before tax | 3.92%1.41M | 3.86%1.7M | -5.25%1.35M | 99.51%1.63M | 112.50%1.43M | 44.67%651K | 150.84%818K | 173.40%803K | 176.28%672K | 137.22%450K |
| Tax | -1.82%-617K | -6.58%-1.21M | 14.65%-606K | -56.03%-1.14M | -93.46%-710K | -44.75%-317K | -119.88%-730K | -720.00%-492K | -1,083.87%-367K | -21,800.00%-219K |
| After-tax profit from continuing operations | 5.62%789K | -2.43%481K | 4.04%747K | 460.23%493K | 135.41%718K | 44.59%334K | 104.53%88K | 126.95%311K | 133.44%305K | 119.09%231K |
| After-tax profit from non-continuing business | ---- | -3.64%-399K | 82.39%-25K | ---385K | ---142K | ---- | ---- | 93.33%-2K | ---- | ---- |
| Earning after tax | 9.28%789K | -24.07%82K | 25.35%722K | 22.73%108K | 88.85%576K | 44.59%334K | 104.58%88K | 126.10%309K | 133.41%305K | 119.74%231K |
| Shareholders should account for profits from continuing business | ---- | -2.43%481K | ---- | --493K | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | -3.64%-399K | ---- | ---385K | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 9.28%789K | -24.07%82K | 25.35%722K | 22.73%108K | 88.85%576K | 44.59%334K | 104.58%88K | 126.10%309K | 133.41%305K | 119.74%231K |
| Basic earnings per share | 4.77%0.0483 | -36.25%0.0051 | 8.22%0.0461 | 11.11%0.008 | 1,538.46%0.0426 | 25.00%0.0025 | 138.30%0.0072 | 122.22%0.0026 | 128.57%0.0026 | 116.81%0.002 |
| Diluted earnings per share | 138.30%0.0072 | |||||||||
| Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.